nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenobarbital—Fosphenytoin—SCN5A—dilated cardiomyopathy	0.0875	0.462	CrCbGaD
Methylphenobarbital—Ethotoin—SCN5A—dilated cardiomyopathy	0.0633	0.334	CrCbGaD
Methylphenobarbital—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—ACTN2—dilated cardiomyopathy	0.0624	0.077	CbGpPWpGaD
Methylphenobarbital—Phenytoin—SCN5A—dilated cardiomyopathy	0.0387	0.204	CrCbGaD
Methylphenobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—ACTN2—dilated cardiomyopathy	0.0308	0.0381	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0204	0.0252	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0166	0.0205	CbGpPWpGaD
Methylphenobarbital—GRIA2—N-cadherin signaling events—GJA1—dilated cardiomyopathy	0.0154	0.019	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0151	0.0186	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0145	0.0179	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0137	0.017	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0118	0.0146	CbGpPWpGaD
Methylphenobarbital—GRIA2—N-cadherin signaling events—RAC1—dilated cardiomyopathy	0.0117	0.0145	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0115	0.0142	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0114	0.014	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0112	0.0138	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0103	0.0127	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0103	0.0127	CbGpPWpGaD
Methylphenobarbital—GABRA6—Ion channel transport—RYR2—dilated cardiomyopathy	0.00986	0.0122	CbGpPWpGaD
Methylphenobarbital—GABRA4—Ion channel transport—RYR2—dilated cardiomyopathy	0.00973	0.012	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0096	0.0119	CbGpPWpGaD
Methylphenobarbital—GABRA6—Ion channel transport—PLN—dilated cardiomyopathy	0.00959	0.0118	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00948	0.0117	CbGpPWpGaD
Methylphenobarbital—GABRA4—Ion channel transport—PLN—dilated cardiomyopathy	0.00947	0.0117	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00907	0.0112	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—ACTN2—dilated cardiomyopathy	0.0087	0.0107	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00868	0.0107	CbGpPWpGaD
Methylphenobarbital—GABRA5—Ion channel transport—RYR2—dilated cardiomyopathy	0.00865	0.0107	CbGpPWpGaD
Methylphenobarbital—GABRA3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00849	0.0105	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00843	0.0104	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00842	0.0104	CbGpPWpGaD
Methylphenobarbital—GABRA5—Ion channel transport—PLN—dilated cardiomyopathy	0.00841	0.0104	CbGpPWpGaD
Methylphenobarbital—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00835	0.0103	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00827	0.0102	CbGpPWpGaD
Methylphenobarbital—GABRA3—Ion channel transport—PLN—dilated cardiomyopathy	0.00826	0.0102	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—ABCC9—dilated cardiomyopathy	0.00825	0.0102	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00813	0.01	CbGpPWpGaD
Methylphenobarbital—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	0.00812	0.01	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—ACTN2—dilated cardiomyopathy	0.00791	0.00976	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00733	0.00905	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00722	0.00891	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00713	0.0088	CbGpPWpGaD
Methylphenobarbital—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00712	0.00878	CbGpPWpGaD
Methylphenobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—RAF1—dilated cardiomyopathy	0.00702	0.00866	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00694	0.00856	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00693	0.00856	CbGpPWpGaD
Methylphenobarbital—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00692	0.00854	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00685	0.00845	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00673	0.0083	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00665	0.00821	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00645	0.00796	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00633	0.00782	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00622	0.00768	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00611	0.00754	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—ABCC9—dilated cardiomyopathy	0.00577	0.00712	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.0057	0.00703	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00567	0.007	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—ACTN2—dilated cardiomyopathy	0.00553	0.00683	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00546	0.00674	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00521	0.00643	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00506	0.00625	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00497	0.00613	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00492	0.00607	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00489	0.00603	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.00485	0.00599	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00477	0.00588	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00468	0.00578	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00462	0.00571	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00429	0.00529	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00417	0.00514	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00401	0.00495	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00399	0.00493	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00387	0.00478	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00344	0.00424	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00343	0.00423	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00339	0.00418	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00334	0.00412	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00334	0.00412	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.0033	0.00407	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.0033	0.00407	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00313	0.00386	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.0031	0.00383	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00306	0.00378	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00304	0.00375	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00301	0.00371	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00296	0.00365	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00293	0.00361	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00293	0.00361	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.0029	0.00358	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00288	0.00355	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00288	0.00355	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00286	0.00353	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00283	0.00349	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00283	0.00349	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00272	0.00336	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00267	0.0033	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00263	0.00324	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00263	0.00324	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00258	0.00319	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.00257	0.00317	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00255	0.00314	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00248	0.00306	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00248	0.00306	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00241	0.00297	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00241	0.00297	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00235	0.0029	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00224	0.00276	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00219	0.0027	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00216	0.00266	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—RAF1—dilated cardiomyopathy	0.00198	0.00244	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00198	0.00244	CbGpPWpGaD
Methylphenobarbital—GABRA6—Ion channel transport—RAF1—dilated cardiomyopathy	0.00194	0.0024	CbGpPWpGaD
Methylphenobarbital—GABRA4—Ion channel transport—RAF1—dilated cardiomyopathy	0.00192	0.00237	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00192	0.00237	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00192	0.00236	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00188	0.00232	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00188	0.00232	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00187	0.00231	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00185	0.00228	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—RAF1—dilated cardiomyopathy	0.0018	0.00222	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00177	0.00218	CbGpPWpGaD
Methylphenobarbital—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	0.00171	0.0021	CbGpPWpGaD
Methylphenobarbital—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.00168	0.00207	CbGpPWpGaD
Methylphenobarbital—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00165	0.00203	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00164	0.00203	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00162	0.002	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00158	0.00195	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00153	0.00188	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—RAF1—dilated cardiomyopathy	0.00151	0.00187	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—RAF1—dilated cardiomyopathy	0.00147	0.00181	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00144	0.00178	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00142	0.00175	CbGpPWpGaD
Methylphenobarbital—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.0014	0.00173	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00139	0.00172	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—RAF1—dilated cardiomyopathy	0.00126	0.00155	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—RAF1—dilated cardiomyopathy	0.00124	0.00153	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00119	0.00146	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	0.00111	0.00137	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	0.0011	0.00136	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	0.00108	0.00134	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.00107	0.00131	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	0.00104	0.00128	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000945	0.00117	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	0.000941	0.00116	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000909	0.00112	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000837	0.00103	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000787	0.000971	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000711	0.000878	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000677	0.000835	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000668	0.000824	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000594	0.000733	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000583	0.000719	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000573	0.000707	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000489	0.000603	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000434	0.000535	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000423	0.000521	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00038	0.000469	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	0.000256	0.000316	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	0.000249	0.000307	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	0.000224	0.000277	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	0.000193	0.000238	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	0.000188	0.000232	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	0.000169	0.000209	CbGpPWpGaD
